Nanoparticle approaches to drug delivery for cancer offer exciting and potentially “game-
changing” ways to improve patient care and quality of life in numerous ways, such as …

By the end of 2017 more than 200,000 scientific research articles had been published about
nanomedicine. Out of this vast number only a few of the reported nanoconstructs reached …

Nanomedicine has been extensively explored to enhance the efficacy of chemotherapy with
modest therapeutic efficacy in the clinic, owing to various factors. A primary factor is …

Colon cancer (CC) kills countless people every year throughout the globe. It persists as one
of the highly lethal diseases to be treated because the overall survival rate for CC is meagre …

Metastasis is deadly and also tough to treat as it is much more complicated than the primary
tumour. Anti-metastasis approaches available so far are far from being optimal. A variety of …

Successfully translating anti-cancer nanomedicines from pre-clinical proof of concept to
demonstration of therapeutic value in the clinic is challenging. Having made significant …

The tumor microenvironment (TME) is a very cunning system that enables tumor cells to
escape death post‐traditional antitumor treatments through the comprehensive effect of …

In recent years, significant efforts have been devoted to develop nanotechnology to enhance
the delivery of anticancer drug to tumor tissue while minimizing its distribution and toxicity in …